Drugs / BIIB145
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07225517 | Dec 2025 → Feb 2027 expected | — | Biogen | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIIB145 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07225517 ↗ |
| Route | Oral | “Administered orally” NCT07225517 ↗ |